Advertisement
Advertisement
U.S. markets open in 38 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Genprex, Inc. (GNPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4600-0.0600 (-3.95%)
At close: 04:00PM EDT
Advertisement
Full screen
Loading interactive chart...
  • PR Newswire

    Genprex to Participate in Next Generation Lipid-Based Nanoparticles Delivery Summit

    Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that Company manufacturing leadership will present sessions on cutting edge topics in lipid-based nanoparticle delivery systems at the upcoming Next Generation Lipid-Based Nanoparticles Delivery Summit taking place from July 19-21, 2022 in Boston.

  • PR Newswire

    Genprex to Present at Upcoming June Investor Conferences

    Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the Company's participation in the following upcoming investor and industry conferences to be held in June 2022.

  • PR Newswire

    Genprex to Present at Upcoming Investor Conference in May 2022

    Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its President and Chief Executive Officer, Rodney Varner, will be providing a virtual overview of the Company's gene therapies for cancer and diabetes to investors at the following conference in May 2022.

Advertisement
Advertisement